Skip to Content
Merck
CN

M4141

Methanesulfonic acid solution

4 M (with 0.2% (w/v) tryptamine)

Synonym(s):

Sulfomethane

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
CH3SO3H
CAS Number:
Molecular Weight:
96.11
UNSPSC Code:
12352209
NACRES:
NA.21
PubChem Substance ID:
EC Number:
200-898-6
Beilstein/REAXYS Number:
1446024
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Methanesulfonic acid solution, 4 M (with 0.2% (w/v) tryptamine)

form

liquid

InChI key

AFVFQIVMOAPDHO-UHFFFAOYSA-N

InChI

1S/CH4O3S/c1-5(2,3)4/h1H3,(H,2,3,4)

SMILES string

CS(O)(=O)=O

concentration

4 M (with 0.2% (w/v) tryptamine)

storage temp.

2-8°C

Quality Level

Looking for similar products? Visit Product Comparison Guide

Application

For complete protein and peptide hydrolysis with tryptophan recovery. After hydrolysis the samples are diluted prior to amino acid analysis.

Disclaimer

air sensitive, store under inert conditions

Packaging

Ampules sealed under argon.

pictograms

CorrosionExclamation mark

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

Storage Class

8A - Combustible corrosive hazardous materials

wgk

WGK 2

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Gulfam Ahmad et al.
Frontiers in pharmacology, 11, 556020-556020 (2020-10-13)
Chronic inflammatory bowel disease (IBD) is a condition with multifactorial pathophysiology. To date, there is no permanent cure and the disease is primarily managed by immunosuppressive drugs; long-term use promotes serious side effects including increased risk malignancies. The current study
Luke F Gamon et al.
Redox biology, 36, 101586-101586 (2020-06-07)
The precise characterization and quantification of oxidative protein damage is a significant challenge due to the low abundance, large variety, and heterogeneity of modifications. Mass spectrometry (MS)-based techniques at the peptide level (proteomics) provide a detailed but limited picture due
Chris Twelves et al.
Breast cancer research and treatment, 148(3), 553-561 (2014-11-09)
Data from two phase 3 studies of eribulin were pooled in analyses initially requested by the European Medicines Agency to assess whether specific patient subgroups, previously treated with an anthracycline and a taxane, benefited from eribulin. Study 305/EMBRACE included women
Norio Murai et al.
Organic letters, 14(11), 2818-2821 (2012-05-18)
A one-pot primary aminomethylation of aryl halides, triflates, mesylates, and tosylates via Suzuki-Miyaura cross-coupling reactions with sodium phthalimidomethyltrifluoroborate followed by deamidation with ethylenediamine is reported.
Solvejg Jørgensen et al.
Physical chemistry chemical physics : PCCP, 15(14), 5140-5150 (2013-03-02)
The gas phase reaction between methane sulfonic acid (CH3SO3H; MSA) and the hydroxyl radical (HO), without and with a water molecule, was investigated with DFT-B3LYP and CCSD(T)-F12 methods. For the bare reaction we have found two reaction mechanisms, involving proton

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service